Tumor Organoid Precision Diagnosis

Custom organoid cultures developed from individual patient tumor samples for personalized medicine applications, drug sensitivity testing, and treatment planning in oncology.

Cancer organoid growth kit utilizing organ-on-chip technology to create high-fidelity human tissue models for drug efficacy evaluation and clinical treatment planning. Enables personalized medicine through rapid assessment of therapeutic response and toxicity in cancer research and oncology applications.

A comprehensive organoid culture and development platform designed for creating three-dimensional tissue models from patient or donor cells. The system supports the establishment and maintenance of organoid biobanks for research and therapeutic applications.

An integrated organoid-based system for preclinical drug screening and development, enabling pharmaceutical companies to test compound efficacy on relevant tissue models.

Accurate International Biotechnology provides a comprehensive organoid full lifecycle technology platform for drug development and research. The platform offers high-efficiency screening, precise prediction, controlled risk management, and cost-saving solutions for pharmaceutical enterprises conducting CRO technical services.

Specialized organoid systems designed for tissue regeneration research, including organ-specific models for studying developmental biology and therapeutic regeneration strategies.

TMoC-Lite is a tumor-on-chip system that simulates real tumor microenvironment physiology for preclinical drug evaluation and personalized cancer treatment assessment. The platform accelerates immunotherapy development and personalized oncology applications through ex vivo tissue modeling.

Advanced microfluidic organ-on-a-chip devices that model human organ functions for drug testing and disease research. These systems provide realistic biological microenvironments for preclinical evaluation of therapeutics.

Organ-on-chip microfluidic devices that model human tissue and organ function in vitro for drug testing, toxicology, and disease research. These bioengineered chips integrate multiple cell types in physiologically relevant configurations, enabling predictive evaluation of therapeutic efficacy and safety. Applications include pharmaceutical development, personalized medicine, and reduction of animal testing in preclinical studies.

Specialized microfluidic organ-on-chip platforms for in vitro tissue modeling and drug testing in biomedical research.

Microfluidic platforms designed for high-throughput organoid, spheroid and organ-on-chip culturing and analysis. These systems enable controlled environments for advanced biological research and drug development.

Laboratory models simulating cellular and organ conditions for research purposes in cell biology and tissue engineering studies.